A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the appearance of drug resistance and allow doctors to more rapidly identify the appropriate treatment for patients with life threatening bacterial infections.
In a paper published online this week in the journal EBioMedicine, the scientists reported the development of a rapid susceptibility test for Staphylococcus aureus, a bacterium that causes some 60 percent of hospital-acquired infections and which has spread in communities, causing pneumonia and a variety of skin and tissue infections in both healthy and immune-compromised individuals.
The development is important, say biomedical scientists, because of the critical need for physicians to rapidly discriminate between drug resistant strains (commonly termed MRSA for methicillin-resistant S. aureus) and drug sensitive strains, since these infections can progress rapidly, especially MRSA strains with additional resistance to newer antibiotics designed to treat pathogens that are now appearing in hospitals.
According to the Centers for Disease Control and Prevention, antibiotic resistance causes two million illnesses and 23,000 deaths annually, costing the U.S. economy approximately $20-billion a year in direct health care costs and nearly eight million extra days in the hospital. Indeed, bacteria are evolving resistance to antibiotics much more quickly than global biomedical research efforts are delivering new drugs to market, leading to the appearance of infections caused by bacteria that are now resistant to every therapy.
Rapid antimicrobial susceptibility testing allows doctors to discriminate between infections caused by drug sensitive bacteria, which can be treated with safe and effective antibiotics developed in what scientists call the golden age of drug discovery (the mid-20th century) such as penicillin, and those caused by drug resistant bacteria, which might require newer antibiotics, such as daptomycin or cubicin. This approach will decrease the emergence of resistance by reserving the newest drugs for those infections where they are most needed.
The interdisciplinary team at UC San Diego was comprised of two infectious-disease specialists in the School of Medicine, Victor Nizet, MD, and George Sakoulas, MD; two biologists in the Division of Biological Sciences, Kit and Joe Pogliano; and Diana Quach, a bioengineering graduate student. The scientists applied a method previously developed in the Pogliano laboratories for drug discovery to antibiotic susceptibility testing.
“Previously we developed a microscopy-based method that performs an autopsy on bacterial cells that allows us to determine how each cell died, and we have shown that this method can identify new antibiotics and help understand how these antibiotics work,” said Kit Pogliano, a professor of biology at UC San Diego who headed the research team. “We tested to see if this method could be applied to antibiotic susceptibility testing. Surprisingly, we not only found that our method was able to accurately differentiate sensitive S. aureus strains from resistant MRSA strains, but that we were able to identify two subgroups of MRSA strains, one of which is susceptible to combinations of antibiotics that could be used in the hospital. We are excited by the accuracy and speed of this test, as well as by its unanticipated ability to identify these two types of MRSA infections, which would have been missed by other tests.”
Examining single cells has two key advantages over other testing methods, say the researchers. First, it is rapid, cutting days off the time for typical culture-based assays. It often takes days for a doctor to receive information on resistance, and this means that patients with life-threatening infections are often treated with the assumption that the infection is drug-resistant. Second, this method does not rely on having any detailed understanding of the bacterium causing the infection, or of the genes that convey resistance. This is particularly important in this case, since resistance to the drugs used to treat MRSA infections arise by several evolutionary pathways via different combinations of mutations, and it could also provide rapid treatment information for newly emerging bacterial pathogens, such as that which caused the infections transmitted by endoscopes.
“Regardless of the type of bacterium, a healthy and growing bacterium looks different from a dead bacterium, so whenever we detect a difference in how the cells look, we know that the bacterium is sensitive to the antibiotic we have applied. When we combine careful culture conditions, cutting edge imaging methods and a detailed quantitative analysis, we can turn this simple approach into a reliable test,” said Joe Pogliano, a professor of biology.
“Rapid and precise identification of antibiotic sensitivity patterns allows the most potent and effective drug to be administered,” said Nizet, a professor of pediatrics and pharmacy. “Equally important, more specific antibiotic therapy can help preserve the normal bacteria living in our gut microbiome that play an important role in our health and immune system function.”
The UC San Diego biologists say their new method has the potential to be applied to many different types of bacteria. “Our new method worked surprising well at rapidly detecting antibiotic resistant strains of S. aureus,” said Diana Quach, a graduate student and lead author on the study. “We are now optimizing it to provide a more accurate test for other types of antibiotic resistant bacteria, such as Pseudomonas aeruginosa.”
The Latest on: Antibiotic susceptibility testing
via Google News
The Latest on: Antibiotic susceptibility testing
- OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in ...on April 12, 2021 at 4:32 am
Results of Unyvero LRT BAL were compared to conventional microbiological methods including bacterial culture for pathogen identification and antimicrobial susceptibility testing, as well as ...
- Veterinary Antimicrobial Susceptibility Testing Market Worth $135 Million by 2026 - Exclusive Report by MarketsandMarkets™on April 7, 2021 at 1:10 pm
The veterinary antimicrobial susceptibility testing market is expected to reach $135 million by 2026. Veterinary susceptibility testing market report provides crucial industry insights that will help ...
- My COVID story: "I had symptoms despite getting a negative COVID report"on April 6, 2021 at 12:00 am
The doctor said he can't rule that out, but said that 5 days of antibiotics already taken, may distort the swab test result. Again, knowing my susceptibility to throat-related ailment for long ...
- Drugs Repurposed To Tap Immune System In Fight Against Pathogenson April 5, 2021 at 10:02 pm
One key value of antibiotic susceptibility testing is that it provides an estimate of direct drug action against the bacteria that is the same the world over, says Nizet. But infection in patients is ...
- Antimicrobial Susceptibility Testing Marketon April 4, 2021 at 11:42 pm
The global antimicrobial susceptibility testing market is expected to reach $4.33 billion in 2025 at a CAGR of 5.9%. The Business Research Company offers Antimicrobial Susceptibility Testing ...
- Scientists to meet in Accra to deliberate on combating infectious diseaseson April 1, 2021 at 2:21 pm
“Building a laboratory capacity for microbiology culture and antimicrobial susceptibility testing for patient management is crucial in fighting AMR in developing countries,” states Dr. Kassaye Tekie ...
- Antimicrobial Susceptibility Test Market 2021 : Market Size, Growth, Top Countries Data with Overview and Geographical Forecast Till 2026on March 31, 2021 at 11:53 pm
The MarketWatch News Department was not involved in the creation of this content. Apr 01, 2021 (The Expresswire) -- Global “Antimicrobial Susceptibility Test Market" 2021-2026 Research Report provides ...
- Scientists to meet in Accra to deliberate on ways to strengthen West Africa’s diagnostics & research env. to combat infectious diseaseson March 31, 2021 at 5:10 am
“Building a laboratory capacity for microbiology culture and antimicrobial susceptibility testing for patient management is crucial in fighting AMR in developing countries,” states Dr. Kassaye ...
- More Fun Than Fun: How Do Insect Societies Deal With Infectious Diseases?on March 30, 2021 at 7:29 pm
Colonies of social insects such as those of ants, bees, wasps and termites present parasites with a paradise of sorts: they contain densely packed individuals that are also rather genetically similar ...
- Veterinary Antimicrobial Susceptibility Testing Market by Product, Animal, End-user - Global Forecast to 2026on March 30, 2021 at 3:42 am
The Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, Horse, Cattle, Pig, Poultry), End User ...
via Bing News